FLR
63
4
VRSN
52
3
CCI
33
2
EXPE
80
16
DLTR
62
4
SE
55
-2
HON
59
-3
RL
70
5
PHM
42
-7
KSS
62
3
MDT
48
3
ORLY
60
3
SYK
42
2
PNR
62
2
KR
50
5
NSC
56
2
ACN
40
4
MTCH
62
14
EL
45
12
VIX
47
-11
FLR
63
4
VRSN
52
3
CCI
33
2
EXPE
80
16
DLTR
62
4
SE
55
-2
HON
59
-3
RL
70
5
PHM
42
-7
KSS
62
3
MDT
48
3
ORLY
60
3
SYK
42
2
PNR
62
2
KR
50
5
NSC
56
2
ACN
40
4
MTCH
62
14
EL
45
12
VIX
47
-11
Financhill
Back

Atlas Copco AB 10K Form

Sell
49

ATLKY
Atlas Copco AB

Last Price:
$16.51
Seasonality Move:
6.8%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ATLKY News And Ratings

See the #1 stock for the next 7 days that we like better than ATLKY

ATLKY Financial Statistics

Sales & Book Value

Annual Sales: $16.7B
Cash Flow: $772.8M
Price / Cash Flow: 27.14
Annual Sales: $2.33
Price / Book: 10.44

Profitability

EPS (TTM): 0.55760
Net Income (TTM): $2.7B
Gross Margin: $7B
Return on Equity: 25.49%
Return on Assets: 13.33%

Atlas Copco AB Earnings Forecast

Key Atlas Copco AB Financial Ratios

  • The Gross Profit Margin over the past 45 years for ATLKY is 42.12%.
  • The Selling, General & Administrative Expenses for ATLKY have been equal to 17.59% of Gross Profit Margin.
  • The Research & Development expenses have been 3.50% of Revenue.
  • The Interest Expense is 2.84% of Operating Income.
  • The Net Earning history of ATLKY is 16.85% of Total Revenues.
  • Per Share Earnings over the last 45 years have been positive in 24 years.

Atlas Copco AB Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Machinery
Sector: Industrials
Current Symbol: ATLKY
Website: atlascopco.com

Debt

Debt-to-Equity Ratio: 0.33
Current Ratio: 1.52
Quick Ratio: 1.09

Price-to-Earnings

Trailing P/E Ratio: 28.61
Forward P/E Ratio: 0

ATLKY Technical Analysis vs Fundamental Analysis

Sell
49
Atlas Copco AB (ATLKY) is a Sell

Is Atlas Copco AB a Buy or a Sell?

  • Atlas Copco AB stock is rated a Sell
    The current Atlas Copco AB [ATLKY] share price is $16.51. The Score for ATLKY is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.